Abstract 4143017: Insights for Direct-to-Patient Clinical Trial Recruitment Strategies From the Heartline Study
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: Decentralized clinical trials using direct-to-participant recruitment can potentially engage large, representative participant pools. Research Question: Can a decentralized clinical trial use a multichannel approach to recruit patients >65 years old across the United States? Goals/Aims: To share insights on multichannel strategies for participant recruitment in the decentralized, app-based Heartline study. Methods: Heartline is a randomized trial testing the impact of a mobile app-based heart health program with the electrocardiogram (ECG) and Irregular Rhythm Notification (IRN) features on Apple Watch for early diagnosis, treatment, and outcomes of atrial fibrillation. Eligible participants were US adults aged ≥65 years with an iPhone and Medicare coverage. Multiple pathways for broad outreach were explored, including digital (eg, email, social media) and traditional channels (eg, direct mail, community outreach). Recruitment efforts were assessed and refined to reach a large eligible population. Results: A multichannel approach led to ~300,000 Heartline study app installations. In total, 34,244 participants completed enrollment (Feb 2020-Dec 2022), of whom 28,155 completed baseline demographic assessments. Participants were widely distributed geographically, with notable representation of outlying and rural areas ( Figure 1 ). Women accounted for 54% of the participants. Overall, most participants were White (93.0%), with Asian, Black, and Hispanic participants representing 2.8%, 2.7%, and 2.5%, respectively. Conclusion: The Heartline study demonstrated the ability to recruit large numbers of participants aged ≥65 years using a direct-to-participant approach. Broad outreach strategies ensured gender and geographic diversity, enrolling a higher percentage of women than typical cardiology trials, and participation from rural areas. However, underrepresentation across racial/ethnic groups persisted and strategies to increase enrollment are needed. For similar trials, a strategic multichannel approach, with strong data and analytics capabilities may be beneficial to effectively target and enroll eligible participants.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Abstract 4143017: Insights for Direct-to-Patient Clinical Trial Recruitment Strategies From the Heartline Study
- Date Crossref
- 12/11/2024
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
American Society for Reproductive Medicine pays non établi dans la noticeOrganisation à but non lucratif
-
Baim Institute for Clinical Research pays non établi dans la noticeOrganisation à but non lucratif
-
Beth Israel Deaconess Medical Center Department of Medicine pays non établi dans la noticeÉtablissement de santé
-
Harvard University pays non établi dans la noticeUniversité ou école supérieure
-
St David's Medical Center pays non établi dans la noticeÉtablissement de santé
-
Texas Cardiac Arrhythmia pays non établi dans la noticeÉtablissement de santé
-
Keck Graduate Institute pays non établi dans la noticeUniversité ou école supérieure
-
Tulane University John W. Deming Department of Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Dartmouth College pays non établi dans la noticeUniversité ou école supérieure
-
Providence College pays non établi dans la noticeUniversité ou école supérieure
-
Hope Heart Institute pays non établi dans la noticeOrganisation à but non lucratif
-
Scripps Research Institute pays non établi dans la noticeOrganisation à but non lucratif
American Society for Reproductive Medicine, Baim Institute for Clinical Research et Department of Medicine — Beth Israel Deaconess Medical Center, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.